Trade
Trading Type
Spot
Trade crypto freely
Alpha
Points
Get promising tokens in streamlined on-chain trading
Pre-Market
Trade new tokens before they are officially listed
Margin
Magnify your profit with leverage
Convert & Block Trading
0 Fees
Trade any size with no fees and no slippage
Leveraged Tokens
Get exposure to leveraged positions simply
Futures
Futures
Hundreds of contracts settled in USDT or BTC
Options
HOT
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Participate in events to win generous rewards
Demo Trading
Use virtual funds to experience risk-free trading
Earn
Launch
Investment
Simple Earn
VIP
Earn interests with idle tokens
Auto-Invest
Auto-invest on a regular basis
Dual Investment
Buy low and sell high to take profits from price fluctuations
Quant Fund
VIP
Top asset management team helps you profit without hassle
Crypto Loan
0 Fees
Pledge one crypto to borrow another
Lending Center
One-Stop Lending Hub
VIP Wealth Hub
New
Customized wealth management empowers your assets growth
Private Wealth Management
Customized asset management to grow your digital assets
Staking
Stake cryptos to earn in PoS products
BTC Staking
HOT
Stake BTC and earn 10% APR
GUSD Minting
New
Use USDT/USDC to mint GUSD for treasury-level yields
Soft Staking
Earn rewards with flexible staking
More
- Trending TopicsView More
121.2K Popularity
31.5K Popularity
18.7K Popularity
170.4K Popularity
2.8K Popularity
- Pin
Zhaoyin International: Raises the target price of Stone Pharma Group to HKD 10.08, maintains "Buy" rating.
Jin10 data, June 3rd: CMB International believes that the BD transactions of CSPC Pharmaceutical Group (01093.HK) will be key sustainable drivers for profit rise. Considering the positive contributions from three potential large BD transactions in the short term, the group’s revenue and net profit for 2025 are expected to rise by 5.8% and 30.4% year-on-year, respectively. The bank has raised the target price for CSPC Pharmaceutical Group from HKD 5.71 to HKD 10.08; maintaining a "Buy" rating.